Skip to main content

Dr. John Shen, M.D.

Hematology & Oncology (Hematology & Oncology Physician)

200 Med Plaza, # 365,420,120
Los Angeles, CA 90045

Who else practices at this address →

Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas

Call (818) 995-8044

  • Medicare participating

At a glance

In the NPI registry since
2012
Medicare patients seen, 2024
432

Licensed in California since 2014, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2012Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    CA license A128805 (first issued 2014; current)
  • Geriatric Medicine (Internal Medicine) Physician
    CA license A128805 (first issued 2014; current)
  • Internal Medicine Physician
    CA license A128805 (first issued 2014; current)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Medicare patients and services

Medicare patients, 2024
432
Services billed
57,359
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)8,67011
Injection, denosumab, 1 mg6,06026
Leuprolide acetate (for depot suspension), 7.5 mg76092
Injection, dexamethasone sodium phosphate, 1 mg62524
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg57417
Established patient office or other outpatient visit, 30-39 minutes539239
Injection, ondansetron hydrochloride, per 1 mg49618
Established patient office or other outpatient visit, 40-54 minutes458193
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count279136
Infusion, normal saline solution, 250 cc22273

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Abiraterone Acetate205
Erleada (apalutamide)177
Prednisone
Other prescribers in Los Angeles, CA
145
Nubeqa (darolutamide)137
Xtandi (enzalutamide)119
Orgovyx (relugolix)85
Tamsulosin Hcl
Other prescribers in Los Angeles, CA
46
Potassium Chloride
Other prescribers in Los Angeles, CA
19
Lynparza (olaparib)17
Venlafaxine Hcl Er (venlafaxine hcl)
Other prescribers in Los Angeles, CA
15

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 2 companies reported 11 payments worth $3,753 in total to this clinician.

By company
Onmark, Inc.$3,663
AstraZeneca Pharmaceuticals LP$90.15
By type
Travel and Lodging$2,205
Food and Beverage$1,529
Gift$19.74

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Nov 3, 2025Onmark, Inc.
Nov 3, 2025
Travel and Lodging
travel to Irving, TX
$1,787
Nov 3, 2025Onmark, Inc.
Nov 3, 2025
Travel and Lodging
travel to Irving, TX
$418
Nov 3, 2025Onmark, Inc.
Nov 3, 2025
Gift$19.74

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in California →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $165,760 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Los Angeles

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 9, 2018), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1104183631. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.